Brought to you by www.DealSearchOnline.com
 

January 7, 2013 Issue:
 

Recent Health Care M&A Deals 

The 2012 Billion-Dollar Club –
Slowing Down: Just 31 Buyers Spent $82.6 Billion

Spotlight on: Pharmaceuticals

Webcast Calendar

 

Recent Health Care M&A Deals

BIOTECHNOLOGY

Acquirer

Target

Price

Amarantus BioScience, Inc.

 25 Patents from Power3 Medical Products

$40 thousand

Coronado Biosciences, Inc.

Rights to TSO

$1.5 million

Questcor Pharmaceuticals

BioVectra Inc. 

$50.7 million

HOSPITALS

Acquirer

Target

Price

Southeast Health Center

 Dexter Hospital, LLC

$9.8 million

OTHER

Acquirer

Target

Price

 Brady Corp.

 Precision Dynamics Corp.

 $300 million

 
NEW- The Health Care Services Acquisition Report, 19th Edition – Preorder Today!
Deals have been made. The 2013 Health Care Services Acquisition Report contains private deals in this market that are too small to make into financial press. Take advantage of our limited 2-for-1 offer – preorder The 2013 Health Care Services Acquisition Report by December 31st  and receive The 2012 Health Care Services Acquisition Report FREE ($595 value)! Now that’s a recession resistant deal. Go to http://www.levinassociates.com/hardescription or call 800-248-1668 to preorder today!
 
The 2012 Billion-Dollar Club –
Slowing Down: Just 31 Buyers Spent $82.6 Billion
The U.S. economy is still sluggish, and that seems to be the case in the health care M&A market in 2012.  The number of billion-dollar deals announced by early December was off by 9% compared with 2011, and the combined total spent on those billion-dollar deals decreased by 36.9% compared with the year before.  The year isn’t over yet, of course….Read more
 
Upcoming Interactive M&A Webcast:
Key Growth Sectors in the Health Care Merger & Acquisition Market
Thursday, January 17, 2013, 1:00 pm ET            
Among the dozen or more sectors that make up the health care services industry, a handful has displayed extraordinary growth in the last several quarters. Activity in other sectors has remained fairly consistent — let’s say stable — while a few sectors continue to languish below the radar. Our panel of experts includes: Steve Economou (Moderator), Managing Director, Curtis Financial; Carsten Beith, Managing Director and Group Head, Tax-Exempt M&A, Cain Brothers; Trey Crabb, Managing Director, Ziegler; Stephen M. Monroe, Managing Editor and Partner, Irving Levin Associates, Inc.; and Joshua Nemzoff, President, Nemzoff & Co.
Go to http://www.levinassociates.com/conferences/1301-online-conference or call 800-248-1668 to register.
 
Spotlight on: Pharmaceuticals
Allergan, Inc. (NYSE: AGN), maker of Botox, agreed to pay $350 million upfront for SkinMedica, Inc., a privately held seller of prescription and non-prescription aesthetic skin-care products. In addition to the upfront cash, SkinMedica could receive another $25 million contingent on the acquired products reaching certain sales targets….Read more
 
Conference Calendar…Click here to see more